Home › Neurofibromatosis
Neurofibromatosis clinical trials recruiting in the U.S.
7 studies for Neurofibromatosis are recruiting participants at sites across the United States.
Neurofibromatosis (NF) is a genetic disorder that causes tumors to grow on nerves. Learn about the types, their symptoms, and how they are treated.
Recently updated studies
PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT06961565The NF Registry Sponsored by the Children's Tumor Foundation
RecruitingObservational study
All ages · All sexes · Updated Oct 22, 2026 · NCT01885767Natural History Study of Patients With Neurofibromatosis Type 2
RecruitingObservational study
Ages 8 to 75 · All sexes · Updated Oct 16, 2026 · NCT00598351Glioma Developmental and HyperActive Ras Tumor (DHART) Board
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 31, 2026 · NCT05489783Tailoring an Online Platform to Promote Evidence-Based Care for Adults With Neurofibromatosis 1 and Low Health Literacy
Recruiting
Ages 18 and older · All sexes · Updated Jul 15, 2026 · NCT07233408Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1
RecruitingPhase 1
Ages 18 and older · All sexes · Updated May 8, 2026 · NCT07102394Mirdametinib in Patients With Advanced NF1-mutant Melanoma
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 19, 2025 · NCT07237100From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.